Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
35.9M
-
Shares change
-
+545K
-
Total reported value, excl. options
-
$244M
-
Value change
-
+$2.67M
-
Put/Call ratio
-
425.91
-
Number of buys
-
56
-
Number of sells
-
-48
-
Price
-
$6.79
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q4 2024
136 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q4 2024.
Pulmonx Corp - COMMON STOCK (LUNG) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.9M shares
of 40.4M outstanding shares and own 88.86% of the company stock.
Largest 10 shareholders include FMR LLC (5.92M shares), PRIMECAP MANAGEMENT CO/CA/ (5.51M shares), MORGAN STANLEY (3.07M shares), BlackRock, Inc. (2.85M shares), VANGUARD GROUP INC (2.28M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.53M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.25M shares), DEUTSCHE BANK AG\ (1.1M shares), GEODE CAPITAL MANAGEMENT, LLC (902K shares), and Altium Capital Management LLC (815K shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.